William A.  Kaye MD, FACP's portrait

William A. Kaye MD, FACP

Endocrinologist and Co-director of the Metabolic Research Institute, Inc.
Palm Beach Diabetes and Endocrine Specialists, PA
West Palm Beach, FL

About William A. Kaye MD, FACP

William Kaye MD, FACP received his medical degree from Brown University. Following his internal medicine training at Brown and its affiliated hospitals, Dr. Kaye completed a fellowship at Cornell University Medical Center at New York Hospital and the Sloan-Kettering Cancer Center. He subsequently joined the faculty of the Harvard University Medical School where he served as a consultant to the prestigious Joslin Diabetes Center and the New England Deaconess/Beth Israel Hospital in Boston.
 
In 1985, Dr. Kaye founded Palm Beach Diabetes and Endocrine Specialists, P.A. The past president of the Palm Beach County American Diabetes Association, Dr. Kaye also served as Chief of Endocrinology at both Good Samaritan and St. Mary’s Hospitals. A current member of the Endocrine Society and a Fellow of the American College of Physicians, Dr. Kaye has been named to the list of Top Physicians of America.
 
Over the past several years, Dr. Kaye has presented lectures on various endocrine diseases at local and national levels. His articles on diabetes, hypertension, kidney disease, and cholesterol disorders have been widely published in the well respected New England Journal and the Archives of Internal Medicine. As a contributing author to the popular magazine, Diabetes Forecast, and the co-director of the Metabolic Research Institute, Inc., he continues to be actively involved in medical research issues. In addition to diabetes, Dr. Kaye maintains a strong interest in osteoporosis, cholesterol metabolism, and obesity, as well as disorders of the thyroid gland.

Publications

Original Reports
Kaye WA. When the Pressure Gets to be Too Much. Diabetes Forecast. August 1993:46-51.

Kaye WA. Diabetes and Hypertension. Diabetes Forecast. April 1989:55-60.

Pawel BR, Kaye WA, Kahn MY, et.al. Aggravation of Diabetic Nephropathy by Lithium. J Clin. Psy. 1989;50:101-103.

Kaye WA. Latest Advances in Diabetic Kidney Disease. Diabetes Forecast. March 1988.

Kaye WA. Understanding Kidney Disease. Diabetes Forecast. Nov. 1987:25-29.

Kaye WA, Adri MNS, Soeldner JS, et.al. Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes Mellitus. N Eng J Med. 1986;315:920-924.

Elia JA, Kaldany A, Miller DG, Yoburn DC, Kaye WA, Weinrauch LA. The Management of the Diabetic Patient with Renal Disease. Comprehensive Therapy. 1984;10(4):39-47.

Suthanthiran M, Kaye WA, Rubin AL, Stensel KH. Interleukin-2 Profiles in Renal Graft Recipients. Transplant Proceed. 1984;16(6):1473-1474.

Elia JA, Kaldany A, Miller DG, Yoburn DC, Kaye WA. Moxalactam, Bleeding and Renal InsufficiencyJAMA. 1983;249(12):1565 ( letter).

Suthanthiran M, Kaye WA, Vogel RM, et.al. Immunosurveillance Mechanisms Operative in Renal Allograph Recipients. Transplant Proceed. 1983:15:1800.

Kaye WA, Passero M, Soloman R, Johnson L. Cimetidine-Induced Interstitial Nephritis with Response to Prednisone. Arch Inter Med. 1983;143:811-812.

Kaye WA, Griffith WC, Camara PD, Trebbin WM, Soloman RJ, Diamond J. The Significance of B2-Microglobulinuria Assoicated with Gentamicin Therapy. Ann Clin Lab Sci. 1981;11:530-527.

Kaye WA, Passero MA. Respiratory Distress & Hypoxemia in Mastocytosis. Chest. 1979;75:87.

Abstracts
Kaye WA, Griffith WC, Trebbin WM, Solomen RJ, Diamond J. B2-Microglobulinuria with Gentamicin Therapy. Clin Chem. 1979;25:1071.

Kaye WA, Griffith WC, Camara PD, Trebbin WM, Solomen RJ, Diamond J. Gentamicin Induces B-2 Microglobulinuria. Clin Rs Oct. 19;27:600A. Presented at American Federation for the Clinical Research, Eastern Section.

Suthanthiran M, Kaye WA, Rubin AL, Novogrodsky A, Stenzel KH. Lymphocyte Activation in Renal Allograph Recipients: Analysis at the Level of Production and Response to Interleukin-2. Kidney Int. 1983;23:296.

Kaye WA, Adri MNS, Kaldany A, Soeldner JS, Eisenbarth GS. Interleukin-2 Deficiency in Type I Diabetes Mellitus. Clin Res. Vol 333 434A, 1985. Presented May 4, 1985, American Federation for Clinical Research, Washington, DC.

Kaye WA, Kaldany A, D’Elia JA, Adri MNS, Monaco AP. Renal Transplantation Decreased IL-2 Production. Clin Res. Vol. 32 3395A, 1984.

Raskin P, McGill J, Saad MF., Cappleman JM, Kaye W, Khutoryansky N, Hale PM. Combination Therapy for Type 2 Diabetes: repaglinide plus rosiglitazone. Diabetic Medicine. Vol 21 Page 329-April 2004.

Financial Disclosures for William A. Kaye MD, FACP

EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, or an immediate family member, have a financial interest(s) or affiliation(s) with the following commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Vertical Health, LLC’s websites.

Disclosed Relationships

Speakers' Bureau
Takeda, Roche, Sanofi-Aventis, Astra-Zeneca, Lilly, Merck, Amylin, Abbott, Pfizer
Other Financial or Material Support
Co-director of the Metabolic Research Institute
SHOW MAIN MENU
SHOW SUB MENU